ICU Medical (ICUI) Set to Announce Earnings on Wednesday

Share on StockTwits

ICU Medical (NASDAQ:ICUI) will be posting its quarterly earnings results after the market closes on Wednesday, August 7th. Analysts expect ICU Medical to post earnings of $1.86 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 EPS for the quarter, topping the Zacks’ consensus estimate of $1.96 by $0.39. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The firm had revenue of $330.93 million during the quarter, compared to analyst estimates of $318.97 million. During the same period last year, the company earned $2.26 earnings per share. The business’s revenue for the quarter was down 11.0% on a year-over-year basis. On average, analysts expect ICU Medical to post $9 EPS for the current fiscal year and $9 EPS for the next fiscal year.

ICU Medical stock opened at $247.46 on Tuesday. ICU Medical has a one year low of $210.94 and a one year high of $321.70. The stock has a fifty day moving average of $250.17. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 32.10 and a beta of 0.81.

In related news, COO Christian B. Voigtlander sold 5,348 shares of ICU Medical stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $227.59, for a total transaction of $1,217,151.32. Following the completion of the sale, the chief operating officer now owns 4,732 shares of the company’s stock, valued at $1,076,955.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Scott E. Lamb sold 25,000 shares of ICU Medical stock in a transaction on Wednesday, June 26th. The shares were sold at an average price of $250.00, for a total value of $6,250,000.00. Following the sale, the chief financial officer now directly owns 34,984 shares of the company’s stock, valued at approximately $8,746,000. The disclosure for this sale can be found here. Insiders have sold 37,931 shares of company stock valued at $9,228,056 in the last three months. 11.40% of the stock is owned by corporate insiders.

A number of equities analysts have recently commented on the company. TheStreet raised ICU Medical from a “c+” rating to a “b” rating in a report on Friday, May 10th. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, July 25th. Finally, BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. ICU Medical currently has an average rating of “Buy” and a consensus price target of $290.50.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Read More: What is systematic risk?

Earnings History for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Keybank National Association OH Purchases Shares of 15,561 Silgan Holdings Inc.
Keybank National Association OH Purchases Shares of 15,561 Silgan Holdings Inc.
Keybank National Association OH Acquires New Stake in CBIZ, Inc.
Keybank National Association OH Acquires New Stake in CBIZ, Inc.
Keybank National Association OH Grows Stock Position in Antero Midstream GP LP
Keybank National Association OH Grows Stock Position in Antero Midstream GP LP
Keybank National Association OH Trims Stake in Vanguard Value ETF
Keybank National Association OH Trims Stake in Vanguard Value ETF
Keybank National Association OH Purchases 2,905 Shares of iShares Edge MSCI USA Value Factor ETF
Keybank National Association OH Purchases 2,905 Shares of iShares Edge MSCI USA Value Factor ETF
Keybank National Association OH Lowers Stake in TransUnion
Keybank National Association OH Lowers Stake in TransUnion


© 2006-2019 Ticker Report